期刊文献+

Apollon特异性siRNA序列的筛选及功能鉴定

Screening and verification of the siRNA targeting Apollon
原文传递
导出
摘要 目的 筛选干扰Apollon基因表达的siRNA序列并鉴定其功能.方法 采用化学方法合成针对Apollon基因不同位点的siRNA序列;应用Lipofectamine 2000转染人类乳腺癌MCF-7细胞;反转录PCR(RT-PCR)检测Apollon mRNA表达水平;细胞免疫荧光结合激光共聚焦技术定量分析Apollon蛋白的表达;四甲基偶氮唑蓝(MTT)和流式细胞术分别检测siRNA干扰Apollon后对MCF-7细胞增殖和凋亡的影响.结果 合成的3对siRNA序列均能抑制Apollon mRNA表达,其siRNA1、siRNA2、siRNA3对ApollonmRNA的抑制率分别为(36.201±11.629)%、(67.308±7.686)%、(47.123±12.000)%,与对照组相比差异均有统计学意义(均P< 0.05);siRNA2转染MCF-7细胞后Apollon蛋白的荧光强度为(14.97±2.08)%,增殖抑制率达(73.361±2.118)%,凋亡率为(28.793±0.743)%.结论 筛选出的siRNA2序列可有效沉默Apollon基因的表达,显著抑制MCF-7细胞的增殖和促进其凋亡,为肿瘤靶向治疗提供实验依据. Objective To screen siRNAs that can effectively inhibit Apollon gene expression and determine the cellular functions of those siRNAs.Methods A chemical synthesis method was used to synthesize 3 siRNA sequences against different sites of Apollon.They were transfected into the human breast cancer MCF-7 cells by using Lipofectamine 2000.mRNA level of Apollon was determined by reverse transcription-polymerase chain reaction (RT-PCR).Cellular immunity fluorescence quantitative analysis combined with confocal laser technology was used to determine the protein level of Apollon.Methyl thiazolyl tetrazolium bromide (MTT) assay and flow cytometry were used to determine the effects of siRNA targeting Apollon on proliferation and apoptosis of MCF-7 cells,respectively.Results Three pairs of siRNA could significantly inhibit Apollon mRNA expression,at the inhibition rates of (36.201±11.629) %,(67.308±7.686) %and (47.123±12.000) %,respectively (P 〈 0.05).After tranfection by siRNA2,Apollon protein fluorescence intensity was (14.97±2.08) % compared with control cells.The cell proliferation MCF-7 was inhibited by (73.361±2.118) %and apoptosis was increased by (28.793±0.743) %.Conclusions Screened siRNA2 effectively silences Apollon gene expression,effectively inhibits the proliferation and increases the apoptosis of MCF-7 cells.This provids the foundation for its clinical application in cancer therapy.
出处 《白血病.淋巴瘤》 CAS 2014年第3期148-151,155,共5页 Journal of Leukemia & Lymphoma
基金 基金项目:山东省科学技术发展计划(2010GSF10264)
关键词 肿瘤 Apollon基因 RNA 小分子干扰 MCF-7细胞 Neoplasms Apollon gene RNA,small interfering MCF-7 cell
  • 相关文献

参考文献10

  • 1Lopergolo A, Pennati M, Gandellini P, et al. Apollon gene silencing induces apoptosis in breast cancer ceils through p53 stabilisation and caspase-3 activation[J]. Br J Cancer, 2009, 100: 739-746.
  • 2Olivieri D, Sykora MM, Sachidanandam R, et al. An in vivo RNAi assayidentifies major genetic and cellular requirements for primary piRNA biogenesis in Drosophila[J]. EMBO J, 2010, 29:3301-3317.
  • 3Hao Y, Sekine K, Kawabata A, et al. Apollon ubiquitinates SMAC and caspase-9, and has an essential cyto-protection funation. Nat Cell Biol, 2004, 6: 849-860.
  • 4Srinivasula SM, Ashwell JD. IAPs: what's in a Name?[J]. Mol Cell, 2008, 30: 123-135.
  • 5Van Houdt WJ, Emmink BL, Pham TV, et al.Comparative pmteomics of colon cancer stem ceils and differentiated tumor cells identifies BIRC6 as a potential therapeutic target[J]. Mol Cell Proteomics, 2011, 10: M 111. 011353.
  • 6Smolewski P, Robak T. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies[J]. Curt" Mol Med, 2011, 11: 633-649.
  • 7rvai K, Nagy K, Barti-Juh~tsz H, et al. Molecular profiling of parathyroid hyperplasia, adenoma and carcinoma[J]. Pathol Oncol Res, 2012, 18: 607-614.
  • 8Ismail EA, Mahmoud HM, Tawfik LM, et al. BIRC6/Apollon gene expression in childhood acute leukemia:impact on therapeutic response and prognosis.Haematology[J]. Eur J Haematol, 2012, 88: 118-127.
  • 9陈建发,李宇华,陈引香,谢奎龙,傅明,李立.ApollonsiRNA提高肝癌细胞化疗敏感性的实验研究[J].南方医科大学学报,2011,31(10):1701-1704. 被引量:11
  • 10Pennati M, Millo E, Gandellini P, et al. RNA interference-mediated validation of survivin and apollon/BRUCE as new therapeutic targets for cancer therapy[J]. Curl" Top Med Chem, 2012, 12: 69-78.

二级参考文献15

  • 1Bruix J, Boix L, Sala M, et al. Focus on hepatocellular carcinoma [J]. Cancer Cell, 2004, 5(3): 215-9.
  • 2Braillon A. Hepatocellular carcinoma and evidence-based surgery[J]. World J Gastroenterol, 2009, 15(42): 5371.
  • 3Cohn AL, Myers JW, Mamus S, et al. A phase Ⅱ study of pemetrexed in patients with advanced hepatocellular carcinoma[J]. Invest New Drugs, 2008, 26(4): 381-6.
  • 4Wen-Homg W, Hullinger RL, Andrisani OM. Hepatitis B virus X protein via the p38MAPK pathway induces E2F1 release and ATR kinase activation mediating p53 apoptosis [J]. J Biol Chem, 2008, 283(37): 25455-67.
  • 5Green DR, Evan GI. A matter of Life and death [J]. Cancer Cell, 2002, 1(1): 19-30.
  • 6Srinivasula SM, Ashwell JD. IAPs: what's in a Name[J]? Mol Cell, 2008, 30(2): 123-35.
  • 7Hong X, Lei L, Glas R. Tumors acquire inhibitor of apoptosis protein (IAP)-mediated apoptosis resistance through altered specificity of cytosolic proteolysis [J]. J Exp Med, 2003, 197(12): 1731-43.
  • 8Yang L, Cao Z, Yan H, et al. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for Cancer specific therapy ~J]. Cancer Res, 2003, 63 (20): 6815-24.
  • 9Chen Z, Naito M, Hori S, et al. A human IAP-family gene, apollon, expressed in human brain Cancer cells [J]. Biochem Biophys Res Commun, 1999, 264(3): 847-54.
  • 10Hao Y, Sekine K, Kawabata A, et al. Apollon ubiquitinates SMAC and caspase-9, and has an essential cytoprotection function[J]. Nat Cell Biol, 2004, 6(9): 849-60.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部